Literature DB >> 12668684

Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells.

Bruno Larrivée1, David R Lane, Ingrid Pollet, Peggy L Olive, R Keith Humphries, Aly Karsan.   

Abstract

Vascular endothelial growth factor (VEGF) and its receptors play an essential role in the formation and maintenance of the hematopoietic and vascular compartments. The VEGF receptor-2 (VEGFR-2) is expressed on a population of hematopoietic cells, although its role in hematopoiesis is still unclear. In this report, we have utilized a strategy to selectively activate VEGFR-2 and study its effects in primary bone marrow cells. We found that VEGFR-2 can maintain the hematopoietic progenitor population in mouse bone marrow cultured in the absence of exogenous cytokines. Maintenance of the hematopoietic progenitor population is due to increased cell survival with minimal effect on proliferation. Progenitor survival is mainly mediated by activation of the phosphatidylinositol 3'-kinase/Akt pathway. Although VEGFR-2 also activated Erk1/2 mitogen-activated protein kinase, it did not induce cell proliferation, and blockade of this pathway only partially decreased VEGFR-2-mediated survival of hematopoietic progenitors. Thus, the role of VEGFR-2 in hematopoiesis is likely to maintain survival of hematopoietic progenitors through the activation of antiapoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668684     DOI: 10.1074/jbc.M212158200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Effects of diabetes mellitus on VEGF-induced proliferation response in bone marrow derived endothelial progenitor cells.

Authors:  Shigetoshi Mieno; Munir Boodhwani; Michael P Robich; Richard T Clements; Neel R Sodha; Frank W Sellke
Journal:  J Card Surg       Date:  2010-09       Impact factor: 1.620

2.  Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Authors:  Yuhui Huang; Xiaolan Chen; Mikhail M Dikov; Sergey V Novitskiy; Claudio A Mosse; Li Yang; David P Carbone
Journal:  Blood       Date:  2007-03-21       Impact factor: 22.113

Review 3.  Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.

Authors:  Shannon S Glaser; Paolo Onori; Candace Wise; Fuguan Yang; Marco Marzioni; Domenico Alvaro; Antonio Franchitto; Romina Mancinelli; Gianfranco Alpini; Md Kamruzzaman Munshi; Eugenio Gaudio
Journal:  Dig Liver Dis       Date:  2010-02-13       Impact factor: 4.088

4.  Genetic reduction of class IA PI-3 kinase activity alters fetal hematopoiesis and competitive repopulating ability of hematopoietic stem cells in vivo.

Authors:  Laura S Haneline; Hilary White; Feng-Chun Yang; Shi Chen; Christie Orschell; Reuben Kapur; David A Ingram
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

5.  Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis.

Authors:  Heather K Bone; Melanie J Welham
Journal:  J Cell Sci       Date:  2007-04-24       Impact factor: 5.285

6.  Circulating hematopoietic progenitor cells are decreased in COPD.

Authors:  William J Janssen; Zulma X Yunt; Alaina Muldrow; Mark T Kearns; Angela Kloepfer; Lea Barthel; Donna L Bratton; Russell P Bowler; Peter M Henson
Journal:  COPD       Date:  2013-11-01       Impact factor: 2.409

Review 7.  Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?

Authors:  Samuel C Wagner; Thomas E Ichim; Hong Ma; Julia Szymanski; Jesus A Perez; Javier Lopez; Vladimir Bogin; Amit N Patel; Francisco M Marincola; Santosh Kesari
Journal:  J Transl Med       Date:  2015-10-29       Impact factor: 5.531

8.  Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation.

Authors:  Marcos Perez-Basterrechea; Alvaro J Obaya; Alvaro Meana; Jesus Otero; Manuel M Esteban
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

9.  Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation.

Authors:  Saloomeh Mokhtari; Evan J Colletti; Anthony Atala; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  Stem Cell Reports       Date:  2016-06-14       Impact factor: 7.765

10.  Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors.

Authors:  R Kumar; M-C Crouthamel; D H Rominger; R R Gontarek; P J Tummino; R A Levin; A G King
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.